H04.039
Chronic enlargement of unspecified lacrimal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic enlargement of the lacrimal gland involves persistent swelling or enlargement of the tear-producing gland located above the outer corner of the eye. This condition can affect eye comfort and appearance, and may be linked to various underlying health issues. Recognizing the signs and understanding potential causes and treatment options is essential for managing this condition effectively.
Causes & Symptoms
Clinical Causes: Chronic inflammatory conditions, such as dacryoadenitis, which can be viral or bacterial Lacrimal gland tumors, benign (pleomorphic adenomas) or malignant Autoimmune diseases like Sjögren’s syndrome or granulomatosis with polyangiitis Chronic infections leading to persistent gland swelling Fibrosis or scarring due to previous infections or inflammation Lacrimal gland cysts or other structural abnormalities
Key Symptoms: Persistent swelling or noticeable enlargement above the outer part of the eye Eye discomfort or tenderness in the affected area Redness and inflammation around the swollen lacrimal gland Decreased tear production potentially leading to dry eye symptoms Discomfort or a feeling of fullness in the upper eyelid Occasional pain or discomfort that worsens with eye movement or touch Possible visible or palpable mass in the lateral eyelid area
Diagnostic & Treatment
Diagnosis Path: Diagnosing chronic enlargement of the lacrimal gland involves a combination of clinical examination and diagnostic testing. An ophthalmologist or an eye specialist typically performs a thorough eye exam, assessing the swelling, tenderness, and any associated symptoms. Additional tests may include: - Imaging studies such as orbital ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to visualize the gland and surrounding structures - Biopsy or fine-needle aspiration biopsy if a tumor or abnormal growth is suspected - Blood tests to detect underlying autoimmune or infectious causes - Tests for specific infections or autoimmune markers as needed These evaluations help determine the underlying cause and guide appropriate management strategies.
Treatment Protocols: Treatment for chronic lacrimal gland enlargement depends on the identified cause: - If inflammation or infection is responsible, anti-inflammatory medications, corticosteroids, or antibiotics may be prescribed. - For autoimmune-related conditions, immunosuppressive therapy might be necessary. - When a benign or malignant tumor is diagnosed, surgical removal or other oncologic treatments could be recommended. - Regular monitoring and follow-up are essential to assess response to treatment and detect any progression or recurrence. - Supportive care, such as artificial tears, may be advised to alleviate dry eye symptoms. Early diagnosis and tailored treatment approaches improve outcomes and help preserve eye health.
Clinical Advice & FAQs
Billing Guidance
Is H04.039 a billable ICD-10 code?
Yes, H04.039 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H04.039?
Clinical documentation must specify the nature of Chronic enlargement of unspecified lacrimal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
